Checkpoint-inhibition in ovarian cancer: rising star or just a dream?-Reference-Cited by-同舟云学术

Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

Published:2018 Issue:6 Volume:29 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Pietzner Klaus¹,Nasser Sara¹,Alavi Sara¹,Darb-Esfahani Silvia²,Passler Mona¹,Muallem Mustafa Zelal¹,Sehouli Jalid¹

Affiliation:

1. Department of Gynecology, European Competence Center for Ovarian Cancer (EKZE), Charité-University Medicine of Berlin, Campus Virchow Klinikum, Berlin, Germany.

2. Department of Pathology, Charité-University Medicine of Berlin, Campus Mitte, Berlin, Germany.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2018.29.e93

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review;Cancers;2023-11-10

2. The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages;Cancer Cell International;2023-10-21

3. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells;Frontiers in Immunology;2023-10-04

4. Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study;Journal of Personalized Medicine;2023-06-26

5. Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab;Frontiers in Ophthalmology;2023-01-05